Last updated on January 2017

Trident II Tritanium Acetabular Shell Outcomes Study


Brief description of study

The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.

Clinical Study Identifier: NCT02999009

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Michael Masini, MD

St. Joseph Mercy Hospital Health System
Ypsilanti, MI United States
  Connect »